ask="N/A"
ask_size="N/A"
average_daily_volume="4887"
bid="2.61"
bid_size="2500"
book_value="0.95"
change="+0.00"
change_from_200_day_moving_average="-0.41"
change_from_50_day_moving_average="-0.29"
change_from_52_week_high="-2.55"
change_From_52_week_low="0.19"
change_in_percent="+0.00%"
close="2.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.44"
ebitda="-13.32M"
eps_estimate_current_year="N/A"
eps_estimate_next_quarter="-0.07"
eps_estimate_next_year="-0.33"
ex_dividend_date="N/A"
float_shares="23083000"
high="2.70"
high_52_weeks="5.25"
last_trade_date="1/30/2017"
last_trade_price="2.70"
last_trade_size="100"
last_trade_time="11:51am"
low="2.53"
low_52_weeks="2.51"
market_capitalization="96.49M"
moving_average_200_day="3.11"
moving_average_50_day="2.99"
name="Oasmia Pharmaceutical AB"
notes="N/A"
one_year_target_price="6.00"
open="2.53"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-13.32%"
percent_change_from_50_day_moving_average="-9.74%"
percent_change_from_52_week_high="-48.57%"
percent_change_from_52_week_low="+7.57%"
previous_close="2.70"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="2.83"
price_per_sales="52.93"
revenue="1.82M"
shares_outstanding="35736000"
short_ratio="2.94"
stock_exchange="NCM"
symbol="OASM"
volume="3300"
weeks_range_52="2.51 - 5.25"
